Literature DB >> 18839022

Ischemic preconditioning induces chaperone hsp70 expression and inhibits protein aggregation in the CA1 neurons of rats.

Peng-Fei Ge1, Tian-Fei Luo, Ji-Zhou Zhang, Da-Wei Chen, Yong-Xin Luan, Shuang-Lin Fu.   

Abstract

OBJECTIVE: To investigate the effect of ischemic preconditioning on chaperone hsp70 expression and protein aggregation in the CA1 neurons of rats, and to further explore its potential neuroprotective mechanism.
METHODS: Two-vesseloccluded transient global ischemia rat model was used. The rats were divided into sublethal 3-min ischemia group, lethal 10-min ischemia group and ischemic preconditioning group. Neuronal death in the CA1 region was observed by hematoxylineosin staining, and number of live neurons was assessed by cell counting under a light microscope. Immunochemistry and laser scanning confocal microscopy were used to observe the distribution of chaperone hsp70 in the CA1 neurons. Differential centrifuge was used to isolate cytosol, nucleus and protein aggregates fractions. Western blot was used to analyze the quantitative alterations of protein aggregates and inducible chaperone hsp70 in cellular fractions and in protein aggregates under different ischemic conditions.
RESULTS: Histological examination showed that ischemic preconditioning significantly reduced delayed neuronal death in the hippocampus CA1 region (P < 0.01 vs 10-min ischemia group). Sublethal ischemic preconditioning induced chaperone hsp70 expression in the CA1 neurons after 24 h reperfusion following 10-min ischemia. Induced-hsp70 combined with the abnormal proteins produced during the secondary lethal 10-min ischemia and inhibited the formation of cytotoxic protein aggregates (P < 0.01 vs 10-min ischemia group).
CONCLUSION: Ischemic preconditioning induced chaperone hsp70 expression and inhibited protein aggregates formation in the CA1 neurons when suffered secondary lethal ischemia, which may protect neurons from death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18839022      PMCID: PMC5552536          DOI: 10.1007/s12264-008-0623-3

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  29 in total

Review 1.  Molecular chaperone function of mammalian Hsp70 and Hsp40--a review.

Authors:  K Ohtsuka; M Hata
Journal:  Int J Hyperthermia       Date:  2000 May-Jun       Impact factor: 3.914

Review 2.  Folding of newly translated proteins in vivo: the role of molecular chaperones.

Authors:  J Frydman
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 3.  The regulation of proteasome degradation by multi-ubiquitin chain binding proteins.

Authors:  Jayne Miller; Colin Gordon
Journal:  FEBS Lett       Date:  2005-03-31       Impact factor: 4.124

4.  Protein aggregation after focal brain ischemia and reperfusion.

Authors:  B R Hu; S Janelidze; M D Ginsberg; R Busto; M Perez-Pinzon; T J Sick; B K Siesjö; C L Liu
Journal:  J Cereb Blood Flow Metab       Date:  2001-07       Impact factor: 6.200

5.  Induced tolerance to ischemia in gerbil hippocampal neurons.

Authors:  T Kirino; Y Tsujita; A Tamura
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

6.  Subcellular stress response after traumatic brain injury.

Authors:  Jessie S Truettner; Bingren Hu; Ofelia F Alonso; Helen M Bramlett; Koichi Kokame; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2007-04       Impact factor: 5.269

Review 7.  Biochemistry and molecular biology of tauopathies.

Authors:  Masato Hasegawa
Journal:  Neuropathology       Date:  2006-10       Impact factor: 1.906

8.  Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells.

Authors:  Qishan Wang; Dick D Mosser; Jnanankur Bag
Journal:  Hum Mol Genet       Date:  2005-10-20       Impact factor: 6.150

9.  Co-translational protein aggregation after transient cerebral ischemia.

Authors:  C L Liu; P Ge; F Zhang; B R Hu
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 10.  Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury.

Authors:  Rona G Giffard; Lijun Xu; Heng Zhao; Whitney Carrico; Yibing Ouyang; Yanli Qiao; Robert Sapolsky; Gary Steinberg; Bingren Hu; Midori A Yenari
Journal:  J Exp Biol       Date:  2004-08       Impact factor: 3.312

View more
  6 in total

1.  Possible involvement of oxidative stress and inflammatory mediators in the protective effects of the early preconditioning window against transient global ischemia in rats.

Authors:  Noha N Nassar; Rania M Abdelsalam; Abdel A Abdel-Rahman; Dalaal M Abdallah
Journal:  Neurochem Res       Date:  2011-11-24       Impact factor: 3.996

Review 2.  The mechanisms of brain ischemic insult and potential protective interventions.

Authors:  Zhao-Hui Guo; Feng Li; Wei-Zhi Wang
Journal:  Neurosci Bull       Date:  2009-06       Impact factor: 5.203

3.  Fingolimod affects gene expression profile associated with LPS-induced memory impairment.

Authors:  Rana Omidbakhsh; Banafshe Rajabli; Sanaz Nasoohi; Behzad Khallaghi; Zahurin Mohamed; Murali Naidu; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Exp Brain Res       Date:  2014-08-07       Impact factor: 1.972

4.  Ischemic postconditioning protects neuronal death caused by cerebral ischemia and reperfusion via attenuating protein aggregation.

Authors:  Jianmin Liang; Jihang Yao; Guangming Wang; Ying Wang; Boyu Wang; Pengfei Ge
Journal:  Int J Med Sci       Date:  2012-11-23       Impact factor: 3.738

5.  Ischemic postconditioning alleviates neuronal injury caused by relief of carotid stenosis in a rat model of cerebral hypoperfusion.

Authors:  Chunsheng Feng; Tianfei Luo; Li Qi; Boyu Wang; Yinan Luo; Pengfei Ge
Journal:  Int J Mol Sci       Date:  2012-10-18       Impact factor: 5.923

Review 6.  Neuroprotective effects and mechanisms of ischemic/hypoxic preconditioning on neurological diseases.

Authors:  Jia Liu; Yakun Gu; Mengyuan Guo; Xunming Ji
Journal:  CNS Neurosci Ther       Date:  2021-08       Impact factor: 5.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.